CODX - Co-Diagnostics, Inc.

3.35
0.990   29.552%

Share volume: 229,471
Last Updated: 01-14-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$2.36
0.99
0.42%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
44%
Profitability 25%
Dept financing 50%
Liquidity 72%
Performance 55%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
766.75%
6 Months
984.49%
1 Year
587.32%
2 Year
196.46%
Key data
Stock price
$3.35
P/E Ratio 
0.00
DAY RANGE
$2.46 - $3.49
EPS 
-$0.99
52 WEEK RANGE
$0.17 - $6.35
52 WEEK CHANGE
$580.20
MARKET CAP 
13.252 M
YIELD 
N/A
SHARES OUTSTANDING 
60.893 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
1.27
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Dwight H. Egan
Region: US
Website: codiagnostics.com
Employees: 100
IPO year: 2017
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Co-Diagnostics, Inc. develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and analysis of nucleic acid molecules. Company also provides tests that identify genetic traits in plant and animal genomes. Company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Recent news